Trump Signals No Rush on Iran Deal Maintains Naval Blockade as Critics Face Scrutiny European Shares Flat as US Strikes on Iran Raise Geopolitical Uncertainty French Open Prize Money Dispute Top Players Curtail Media Duties in Protest RBN Energy Joins Novi Labs in Strategic Energy Analytics Merger Inside SpaceXs IPO Goldman Sachs and Morgan Stanley Lead Wall Streets Role in Potential RecordBreaking Listing Trumps Corruption and Cynicism A Governance Risk for Markets RCON Q4 2025 Earnings EPS Surprise Beats Estimates Amid Revenue Uncertainty GPI Q1 2026 Earnings EPS Falls Short of Estimates Despite Positive Stock Movement Pathward Financial CASH Q1 2026 Earnings Earnings Miss on Weaker Net Interest Income Stock Edges Up HASI Q1 2026 Earnings EPS Beats Estimates by Double Digits Amid Steady Operational Performance ALAB Q1 2026 Earnings EPS Beat Drives Positive Stock Movement Gerdau SA GGB Q1 2026 Earnings EPS Misses Estimates Stock Rises Slightly Neuberger Real Estate Securities Income Fund NRO Slips Amidst Modest Trading Activity Senti Biosciences SNTI Holds Above Support Edges Higher Toward Key 106 Resistance Sensei Biotherapeutics Inc SNSE Edges Higher Key Levels and Volume Analysis After a Modest Uptick CHACU Plunges Over 10 as Crane Harbor Acquisition Corp Units Test Key Support Dolphin Entertainment DLPN Holds Near Support After Modest Decline Beyond Inc to Acquire Buy Buy Baby Brand Rights Reunite with Bed Bath Beyond EBMT Q1 2026 Earnings EPS Beats Estimates Stock Edges Higher Flex Ltd FLEX Edges Higher Consolidation Near Key Resistance Prudential Financial PRU Slides Slightly Amid Sector Headwinds Key Levels to Watch TG Therapeutics TGTX Slips Modestly as Stock Consolidates Near Key Support Levels Via Transportation Inc VIA Edges Higher Amid Consolidation Key Levels to Watch JE Cleantech Holdings JCSE Edges Higher Testing Key Resistance Level BrandywineGLOBAL Global Income Opportunities Fund BWG Edges Higher Holding Above Key Support American Exceptionalism Acquisition Corp A AEXA Holds Near Resistance Amid Modest Decline Larimar Therapeutics LRMR Holds Steady Near Support After Modest Gain